Sign in

CIK 0000908259

  • Non-accelerated filer
  • Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133679168
Phone
+1 650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 5,000 shares at an average $3.96 ($19,790)
  7. 4 Open-market buy Director bought 50,000 shares at $3.95 ($197,500)
  8. 4 Open-market buy Director bought 20,000 shares at an average $3.93 ($78,508)
  9. 4 Open-market buy Director bought 50,000 shares at $3.85 ($192,300)
  10. 4/A Grant or award Director acquired 40,000 shares (grant or award)
  11. 4/A Grant or award Director acquired 40,000 shares (grant or award)
  12. 4/A Grant or award Director acquired 40,000 shares (grant or award)
  13. 4/A Grant or award Director acquired 40,000 shares (grant or award)
  14. 4/A Grant or award Chief Operating Officer acquired 40,000 shares (grant or award)
  15. 4/A Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  16. 4/A Grant or award Chief Scientific Officer acquired 80,000 shares (grant or award)
  17. 4/A Grant or award President and CEO acquired 80,000 shares (grant or award)
  18. 4/A Grant or award Director acquired 80,000 shares (grant or award)
  19. 4 Open-market buy Director bought 100,000 shares at $5.09 ($509,000)
  20. 4 Grant or award Director acquired 40,000 shares (grant or award)

Page 12 of 17 · 325 filings